A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease

Completed · Phase 3 · Has a placebo group

Conditions studied: Dry Eye Syndrome

In brief

A dose ranging study to evaluate safety and efficacy of bromfenac ophthalmic solution in dry eye disease.

Key facts

Study ID

NCT01212471

Run by

Bausch & Lomb Incorporated

People needed

840

Starts

2010-09-01

Expected to finish

2011-12-01

Last updated by the study team

2020-09-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be of either gender and any race 18 years or older

You may not qualify if…

• Have a local or systemic disease that could interfere with the assessment of safety or efficacy or that is likely to result in early discontinuation from the study

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.